Drug Approval | September 28, 2022
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
This will be an added advantage for Supriya Lifescience Limited in the European market.
This will be an added advantage for Supriya Lifescience Limited in the European market.
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Women emerge as the cornerstone of this monumental undertaking
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
